Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization-Reference-Cited by-同舟云学术

Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization

Published:2007-05 Issue:5 Volume:47 Page:781-787
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Senzel Lisa,Boulad Farid,Wuest David,Reid Marion E.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2007.01190.x/fullpdf

Reference29 articles.

1. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia

2. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia

3. Coexistence of Two Functioning T-Cell Repertoires in Healthy Ex-Thalassemics Bearing a Persistent Mixed Chimerism Years After Bone Marrow Transplantation

4. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease

5. 5. MC Walters . Stem cell therapy for sickle cell disease: transplantation and gene therapy . Hematology (Am Soc Hematol Educ Prog)2005 :66 -73 .

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation;Transfusion;2018-09-28

2. Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study;The Lancet Haematology;2017-11

3. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation;Blood;2008-10-15

4. Optimizing the use of limited rare red cells for hematopoietic cell transplant recipients;Transfusion;2007-05